A Serum Marker for Early Pancreatic Cancer With a Possible Link to Diabetes

Abstract

Background Pancreatic cancer (PC) has a grim prognosis, and an early diagnostic biomarker has been highly desired. The molecular link between diabetes and PC has not been well-established. Methods Bioinformatics screening was performed for a serum PC marker. Experiments in cell lines (5 PC and 1 normal cell lines), mouse models, and human tissue staining (37 PC and 10 normal cases) were performed to test asprosin production from PC. Asprosin’s diagnostic performance was tested with serums from multi-center cohorts (347 PC, 209 normal, and 55 additional diabetic subjects) and evaluated according to PC status, stages, and diabetic status, which was compared with that of CA19-9. Results Asprosin, a diabetes-related hormone, was found from the bioinformatics screening, and its production from PC was confirmed. Serum asprosin levels from multi-center cohorts yielded an age-adjusted diagnostic AUC of 0.987 (95% confidence interval [CI] = 0.961 to 0.997), superior to that of CA19-9 (AUC = 0.876, 95% CI = 0.847 to 0.905), and a cut-off of 7.18 ng/mL, at which the validation set exhibited a sensitivity of 0.957 and a specificity of 0.924. Importantly, the performance was maintained in early-stage and non-metastatic PC, consistent with the tissue staining. A slightly lower performance against additional diabetic patients (n = 55) was restored by combining asprosin and CA19-9 (AUC = 0.985, 95% CI = 0.975 to 0.995). Conclusion Asprosin is presented as an early-stage PC serum marker that may provide clues for PC-induced diabetes. Larger prospective clinical studies are warranted to solidify its utility.

Metformin Downregulates the Expression of Epidermal Growth Factor Receptor Independent of Lowering Blood Glucose in Oral Squamous Cell Carcinoma

“…Extensive epidemiological studies have shown that T2DM is an emergent contributing systemic factor in pancreatic and Liver ( 17 , 18 ). Other cancers including breast, colorectal, endometrial, and kidney cancer are also related to T2DM, while prostate cancer is negatively related to T2DM ( 5 ).…”

“…The expression of EGFR mediates systemic complications of T2DM that affect the heart, kidneys, and eyes ( 21 ). High-glucose culture of pancreatic cancer cell lines increases the expression of EGF, which then activates EGFR ( 18 ). The neuregulin-1 (Nrg1)-HER3 pathway is upregulated in tumors derived from hyperglycemic patients or rodents ( 22 ).…”

Asprosin, a C-Terminal Cleavage Product of Fibrillin 1 Encoded by the <b><i>FBN1</i></b> Gene, in Health and Disease

“…Although limited, emerging evidence indicates that asprosin is deregulated in several types of human cancers. Asprosin was identified to be a promising predictive marker for the early diagnosis of pancreatic cancer [Nam et al, 2021]. Using immunohistochemical analysis, Kocaman and Artaş [2020] detected higher asprosin immunoreactivity in patients with malignant mesothelioma compared to reactive mesothelial hyperplasia.…”

Chemical Biopsy for GNMT as Noninvasive and Tumorigenesis-Relevant Diagnosis of Liver Cancer

“…The tumor-suppressor bioinformatic screening was performed with a protocol modified from a previous approach. 32 We combined the cholangiocarcinoma (CHOL), liver hepatocellular carcinoma (LIHC), and pancreatic adenocarcinoma (PAAD) datasets to build the liver cancer group (totaling 586 tumor samples and 336 normal samples) since our experiment had shown correlations in the genes among these datasets. It should be noted that this broader inclusion did not have any negative effect on selecting the ultimate candidate, as we manually confirmed all of the final screening outputs.…”